Ep. 163 How EEG Brain Imaging Is Transforming Alzheimer’s and Parkinson’s Treatment

Show Notes:In this episode of the Business Growth Spotlight, Heidi Schalk sits down with James Hamet, CEO and Founder of Vistim Labs, to explore a breakthrough approach to neurological care.Vistim Labs is tackling one of the biggest challenges in neurology: knowing whether a treatment is actually working. While tools like PET scans and MRIs provide structural information, they are expensive, difficult to access, and not designed for frequent monitoring. James shares how Vistim Labs uses advanced EEG based brain imaging to deliver real time, non radioactive insights into brain function in just 30 minutes.The conversation dives into how this technology helps physicians personalize treatment plans for conditions like Alzheimer’s and Parkinson’s disease. With nearly 40 percent of patients potentially receiving therapies that do not produce results, having measurable feedback can dramatically improve outcomes. By providing objective data, doctors can adjust treatment sooner, build trust with patients, and accelerate progress.James also explains the science behind neurofeedback and how measurable feedback drives neuroplasticity. From retraining fall prevention responses in elderly patients to supporting cognitive recovery, feedback loops are central to measurable improvement in both medicine and performance.Beyond the science, this episode explores the realities of building a high tech medical company. James discusses regulatory hurdles, insurance reimbursement challenges, long sales cycles, and the importance of humility and generosity in scaling innovation. He shares why scientific conferences have been his most effective growth strategy and how physician education remains a critical focus.A powerful takeaway from this conversation is that Alzheimer’s disease is not necessarily a hopeless diagnosis. Emerging research and measurable treatment monitoring are changing what is possible.Key topics covered include• How EEG based brain imaging compares to PET scans • The importance of treatment monitoring in neurology • Personalized therapy for Alzheimer’s and Parkinson’s disease • Neurofeedback and brain plasticity • FDA approval and reimbursement challenges in medical innovation • Scaling a mission driven biotech startup • Increasing access to neurological diagnostics across the United StatesTo learn more or connect with James, visit vistimlabs.com.If you are a neurologist, physician, patient, or know someone navigating a neurological condition, this episode is one you will want to share.Bio:Serial neurotechnology entrepreneur, specialized in brain imagingTo connect with our guest, click on the links below:LinkedIn:  https://www.linkedin.com/in/jchamet/Website:  https://vistimlabs.comConnect with me:LinkedIn:  https://www.linkedin.com/in/heidischalkcoaching/🎁 Grab your Spotlight to Scale Blueprint: https://spotlighttoscale.com/blueprint